The Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2018
At a glance
- Drugs Tesamorelin (Primary)
- Indications Brain injuries
- Focus Therapeutic Use
- 09 Mar 2017 Planned primary completion date changed from 31 Dec 2018 to 8 Mar 2017.
- 09 Mar 2017 Planned End Date changed from 31 Dec 2018 to 8 Mar 2017.
- 09 Mar 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.